180 related articles for article (PubMed ID: 26826083)
21. Biologic markers in endometrial cancer treatment.
Engelsen IB; Akslen LA; Salvesen HB
APMIS; 2009 Oct; 117(10):693-707. PubMed ID: 19775337
[TBL] [Abstract][Full Text] [Related]
22. [Impact of 2009 FIGO staging system on the diagnostic value of preoperative MRI staging of endometrial carcinoma].
Yu XD; Ouyang H; Lin M; Zhou CW; Zhang R
Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):692-6. PubMed ID: 22340052
[TBL] [Abstract][Full Text] [Related]
23. Molecular genetic characterization of tamoxifen-associated endometrial cancer.
Prasad M; Wang H; Douglas W; Barakat RR; Ellenson LH
Gynecol Oncol; 2005 Jan; 96(1):25-31. PubMed ID: 15589576
[TBL] [Abstract][Full Text] [Related]
24. Endometrial cancer.
Buchanan EM; Weinstein LC; Hillson C
Am Fam Physician; 2009 Nov; 80(10):1075-80. PubMed ID: 19904892
[TBL] [Abstract][Full Text] [Related]
25. Intraoperative lymphatic mapping techniques for endometrial cancer.
Mais V; Cirronis MG; Piras B; Silvetti E; Cossu E; Melis GB
Expert Rev Anticancer Ther; 2011 Jan; 11(1):83-93. PubMed ID: 21166513
[TBL] [Abstract][Full Text] [Related]
26. Should endometrial clear cell carcinoma be classified as Type II endometrial carcinoma?
Bae HS; Kim H; Young Kwon S; Kim KR; Song JY; Kim I
Int J Gynecol Pathol; 2015 Jan; 34(1):74-84. PubMed ID: 25473756
[TBL] [Abstract][Full Text] [Related]
27. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
28. Molecular carcinogenesis of endometrial cancer.
Liu FS
Taiwan J Obstet Gynecol; 2007 Mar; 46(1):26-32. PubMed ID: 17389185
[TBL] [Abstract][Full Text] [Related]
29. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
[TBL] [Abstract][Full Text] [Related]
30. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
Ivanov I
Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
[TBL] [Abstract][Full Text] [Related]
31. Comparison between clinical and surgical staging for endometrial cancer in Thailand.
Buranawattanachoke S; Leelahakorn S; Tangjitgamol S; Manusirivithaya S; Khunnarong J
Asian Pac J Cancer Prev; 2009; 10(4):685-90. PubMed ID: 19827895
[TBL] [Abstract][Full Text] [Related]
32. [What are the most appropriate operation procedures for endometrial cancer?].
Aoki D; Udagawa Y; Nozawa S
Gan To Kagaku Ryoho; 1995 Aug; 22(9):1163-8. PubMed ID: 7661567
[TBL] [Abstract][Full Text] [Related]
33. Treatment modalities in endometrial cancer.
Amant F; Moerman P; Neven P; Timmerman D; Van Limbergen E; Vergote I
Curr Opin Oncol; 2007 Sep; 19(5):479-85. PubMed ID: 17762575
[TBL] [Abstract][Full Text] [Related]
34. PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics.
Risinger JI; Hayes K; Maxwell GL; Carney ME; Dodge RK; Barrett JC; Berchuck A
Clin Cancer Res; 1998 Dec; 4(12):3005-10. PubMed ID: 9865913
[TBL] [Abstract][Full Text] [Related]
35. Current Recommendations for Minimally Invasive Surgical Staging in Ovarian Cancer.
Fagotti A; Perelli F; Pedone L; Scambia G
Curr Treat Options Oncol; 2016 Jan; 17(1):3. PubMed ID: 26739150
[TBL] [Abstract][Full Text] [Related]
36. [Differentiated operative therapy of endometrial carcinomas].
Kindermann G
Verh Dtsch Ges Pathol; 1991; 75():378-80. PubMed ID: 1724846
[TBL] [Abstract][Full Text] [Related]
37. Management of endometrial cancer.
Fowler W; Mutch D
Womens Health (Lond); 2008 Sep; 4(5):479-89. PubMed ID: 19072487
[TBL] [Abstract][Full Text] [Related]
38. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
[TBL] [Abstract][Full Text] [Related]
39. Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer.
Chang SJ; Bristow RE; Ryu HS
Ann Surg Oncol; 2012 Dec; 19(13):4059-67. PubMed ID: 22766983
[TBL] [Abstract][Full Text] [Related]
40. Optimal surgical cytoreduction in patients with Stage III and Stage IV endometrial carcinoma: a study of morbidity and survival.
Lambrou NC; Gómez-Marín O; Mirhashemi R; Beach H; Salom E; Almeida-Parra Z; Peñalver M
Gynecol Oncol; 2004 Jun; 93(3):653-8. PubMed ID: 15196860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]